Premium
Effects of ambroxol on Candida albicans growth and biofilm formation
Author(s) -
Rene HernandezDelgadillo,
José MartínezSanmiguel Juan,
Isela SánchezNájera Rosa,
Claudio CabralRomero
Publication year - 2014
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12147
Subject(s) - candida albicans , biofilm , microbiology and biotechnology , ambroxol , chemistry , biology , bacteria , anatomy , genetics
Summary Typically, the onset of candidiasis is characterised by the appearance of a biofilm of Candida albicans, which is associated with several diseases including oral candidiasis in young and elderly people. The objective of this work was to investigate the in vitro fungicidal activity as well as the antibiofilm activity of ambroxol ( AMB ) against C. albicans growth. In the present investigation, the fungicidal activity of AMB was established using the cell viability 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide ( MTT ) assay. Also the minimum inhibitory concentration ( MIC ) of AMB required to inhibit the fungal growth was determined. Simultaneously, the antibiofilm activity of AMB was evaluated using fluorescence microscopy. The study revealed that 2 mg ml −1 of AMB exhibited higher fungicidal activity than 3.3 mg ml −1 of terbinafine, one of most common commercial antifungals. A MIC of 1 mg ml −1 was determined for AMB to interfere with C. albicans growth. Furthermore, AMB was found to be effective in inhibiting the biofilm formation of C. albicans and exerted its fungicidal activity against the fungal cells interspersed in the preformed biofilm. The study suggests a potential role of the mucolytic agent, AMB , as an interesting therapeutic alternative in the treatment of oral candidiasis.